These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 8820627)

  • 1. Glucose tolerance, C-peptide response to glucagon, and thyroid and adrenal functions in relation to auto-antibodies in vitiligo.
    Soliman AT; Al Suweid AR; Gamil H; Khader MM; Afour MG
    J Trop Pediatr; 1996 Feb; 42(1):60. PubMed ID: 8820627
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitiligo and juvenile diabetes mellitus.
    Macaron C; Winter RJ; Traisman HS; Kahan BD; Lasser AE; Green OC
    Arch Dermatol; 1977 Nov; 113(11):1515-7. PubMed ID: 931387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Autoimmune Thyroid Disease in Patients With Progressive and Stable Vitiligo.
    Yazdanpanah MJ; Seyedi Noghabi SA; Taghavi M; Afzal Aghaee M; Zabolinejad N
    J Cutan Med Surg; 2016; 20(2):135-8. PubMed ID: 26318546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-thyroid antibodies and autoimmune diseases in patients with vitiligo].
    Peracchi M; Cavagnini F; Ghislanzoni G
    G Ital Dermatol Minerva Dermatol; 1971 Nov; 46(11):487-91. PubMed ID: 5171287
    [No Abstract]   [Full Text] [Related]  

  • 5. [Genuine vitiligo and its relevance for internal medicine].
    Höfs T
    Z Gesamte Inn Med; 1980 Apr; 35(7):285-9. PubMed ID: 6996361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitiligo and autoantibodies: a systematic review and meta-analysis.
    Liu CW; Huang YC
    J Dtsch Dermatol Ges; 2018 Jul; 16(7):845-851. PubMed ID: 29972626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel FoxD3 Variant Is Associated With Vitiligo and Elevated Thyroid Auto-Antibodies.
    Schunter JA; Löffler D; Wiesner T; Kovacs P; Badenhoop K; Aust G; Tönjes A; Müller P; Baber R; Simon JC; Führer D; Pfäffle RW; Thiery J; Stumvoll M; Kiess W; Kratzsch J; Körner A
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1335-42. PubMed ID: 26267147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Family incidence of latent autoimmune diabetes in adults--case report].
    Szepietowska B; Szelachowska M; Górska M
    Endokrynol Pol; 2006; 57(3):254-7. PubMed ID: 16832790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitiligo, autoimmune thyroiditis: a rare thyroid cancer arising with bone metastates on maxillofacial area.
    Frati R; Frati C; Sassano PP; Antonaci A
    J Exp Clin Cancer Res; 1999 Mar; 18(1):85-7. PubMed ID: 10374684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of peptides specific for antibodies in vitiligo using a phage library.
    Jadali Z; Eslami MB; Sanati MH; Mansouri P; Mahmoudi M; Maghsoudi N; Esfahanian F
    Clin Exp Dermatol; 2005 Nov; 30(6):694-701. PubMed ID: 16197391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo and diabetes mellitus.
    Dawber RP; Bleehen SS; Vallance-Owen J
    Br J Dermatol; 1971 Jun; 84(6):600. PubMed ID: 5557513
    [No Abstract]   [Full Text] [Related]  

  • 12. [Detection of serum autoantibodies to melanocyte and correlation between melanoma antigen recognized by T-cells and vitiligo in children].
    Chen JP; Li HP; Jin SH; Zhang JT; Li J
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2107-8, 2111. PubMed ID: 19861278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating autoantibodies and autoimmune comorbidities in vitiligo patients: a multicenter Italian study.
    Ingordo V; Cazzaniga S; Raone B; Digiuseppe MD; Musumeci ML; Fai D; Pellegrino M; Pezzarossa E; Di Lernia V; Battarra VC; Sirna R; Patrizi A; Naldi L
    Dermatology; 2014; 228(3):240-9. PubMed ID: 24603479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rethinking screening for thyroid autoimmunity in vitiligo.
    Liu M; Murphy E; Amerson EH
    J Am Acad Dermatol; 2016 Dec; 75(6):1278-1280. PubMed ID: 27846959
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo.
    Kemp EH; Emhemad S; Akhtar S; Watson PF; Gawkrodger DJ; Weetman AP
    Exp Dermatol; 2011 Jan; 20(1):35-40. PubMed ID: 21158937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose intolerance in pulmonary tuberculosis.
    Jawad F; Shera AS; Memon R; Ansari G
    J Pak Med Assoc; 1995 Sep; 45(9):237-8. PubMed ID: 8683828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose intolerance in cystic fibrosis.
    Lanng S
    Dan Med Bull; 1997 Feb; 44(1):23-39. PubMed ID: 9062762
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vitiligo and other endocrine complications with an autoimmune basis].
    Herrera Pombo JL; Rodríguez ME; Rovira A; Martínez J; Salvador ML; Pérez Naranjo JM; de Castro A; Orbaneja JG
    Rev Clin Esp; 1982 Dec; 167(5):321-5. PubMed ID: 6897748
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and immunologic aspects of the relation of acquired leukoderma (vitiligo) to thyroid diseases.
    Miklaszewska M; Zukowski W; Dankiewicz J; Nowak A
    Arch Immunol Ther Exp (Warsz); 1972; 20(6):885-92. PubMed ID: 4123759
    [No Abstract]   [Full Text] [Related]  

  • 20. Pancreatic islet cell and thyroid antibodies, and islet cell function in diabetic patients of Mexican-American origin.
    Zeidler A; Frasier SD; Penny R; Stein RB; Nicoloff JT
    J Clin Endocrinol Metab; 1982 May; 54(5):949-54. PubMed ID: 7037824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.